Johnson Matthey (LON:JMAT) Stock Price Crosses Above Two Hundred Day Moving Average of $1,623.91

Johnson Matthey PLC (LON:JMAT - Get Free Report)'s share price passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 1,623.91 ($20.22) and traded as high as GBX 1,782 ($22.18). Johnson Matthey shares last traded at GBX 1,767 ($22.00), with a volume of 291,103 shares trading hands.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on the company. Jefferies Financial Group reissued a "buy" rating and issued a GBX 2,100 ($26.14) price target on shares of Johnson Matthey in a research note on Wednesday, March 20th. Numis Securities reissued a "buy" rating and issued a GBX 2,200 ($27.39) price target on shares of Johnson Matthey in a research note on Wednesday, March 20th. Finally, Berenberg Bank increased their price target on Johnson Matthey from GBX 1,650 ($20.54) to GBX 1,800 ($22.41) and gave the company a "hold" rating in a research note on Monday, April 8th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of GBX 2,010 ($25.02).

View Our Latest Stock Analysis on Johnson Matthey

Johnson Matthey Stock Up 0.1 %

The company has a quick ratio of 0.76, a current ratio of 1.51 and a debt-to-equity ratio of 63.95. The stock has a 50 day simple moving average of GBX 1,699.10 and a 200 day simple moving average of GBX 1,624.93. The stock has a market cap of £3.25 billion, a price-to-earnings ratio of 1,842.71, a PEG ratio of 49,242.50 and a beta of 0.98.


Insider Activity

In related news, insider Stephen Oxley bought 18 shares of the company's stock in a transaction dated Wednesday, March 20th. The shares were bought at an average price of GBX 1,864 ($23.20) per share, for a total transaction of £335.52 ($417.68). Corporate insiders own 0.60% of the company's stock.

Johnson Matthey Company Profile

(Get Free Report)

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.

See Also

Should you invest $1,000 in Johnson Matthey right now?

Before you consider Johnson Matthey, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Johnson Matthey wasn't on the list.

While Johnson Matthey currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Featured Articles and Offers

Search Headlines: